Advertisement
OtherAccelerated Communication

Simian Immunodeficiency Virus Is Susceptible to Inhibition by Carbohydrate-Binding Agents in a Manner Similar to That of HIV: Implications for Further Preclinical Drug Development

Katrien O. François, Joeri Auwerx, Dominique Schols and Jan Balzarini
Molecular Pharmacology August 2008, 74 (2) 330-337; DOI: https://doi.org/10.1124/mol.108.047621
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherAccelerated Communication

Simian Immunodeficiency Virus Is Susceptible to Inhibition by Carbohydrate-Binding Agents in a Manner Similar to That of HIV: Implications for Further Preclinical Drug Development

Katrien O. François, Joeri Auwerx, Dominique Schols and Jan Balzarini
Molecular Pharmacology August 1, 2008, 74 (2) 330-337; DOI: https://doi.org/10.1124/mol.108.047621
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement